AI’s Thinking Limits Exposed by Study
Why it matters: AI’s Thinking Limits Exposed by Study reveals how LLMs like ChatGPT fall short in reasoning and abstract tasks.
Everything AI, Robotics, and IoT
Sanksshep Mahendra is a technology executive with success in driving, vision, strategy, design, and execution of software engineering for the web, mobile, apps, social, voice, IoT, applications along with Machine learning and AI. His expertise lies in partnering with business leaders, powering through roadblocks, and leading global teams to deliver disruptive products that advance the organization’s mission and capture game-changing results in the market. Sanksshep Mahendra has a lot of experience in M&A and compliance, he holds a Master's degree from Pratt Institute and executive education from Massachusetts Institute of Technology, in AI, Robotics, and Automation.
Why it matters: AI’s Thinking Limits Exposed by Study reveals how LLMs like ChatGPT fall short in reasoning and abstract tasks.
Why it matters: AI Disruption Rattles Private Credit Markets as tech-backed loans face risk from generative AI upheaval.
Why it matters: Explore AI and the Future of Relationships how digital tools are reshaping love, empathy, and connection today.
Why it matters: Quantum, AI, Crypto: Bubble or Boom? Explore if 2024’s tech surge is real innovation or risky speculation.
Why it matters: AI Transforming the Future of Physics explores how AI accelerates discovery across particle and quantum research.
Why it matters: Microsoft’s AI Thirst Fuels Water Worries as data centers drive a surge in global freshwater consumption.
Why it matters: When AI Feeds the Mind’s Shadows explores AI-linked paranoia, delusions, and the rise of digital mental distress.
Why it matters: MoltBook: Inside an AI-Only Network explores a bot-run social platform where no humans ever log in.
Why it matters: AI Chip Wars: Amazon, Google, Nvidia explores how custom chips are reshaping AI performance and cloud dominance.
Why it matters: AI Tool Maps 71M Gene Mutations using DeepMind’s AlphaMissense to predict disease impact with high accuracy.









